Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Exploring Mitochondrial Function and Chemical Toxicity Using Drosophila melanogaster
Published on: November 10, 2023
RIP1 maintains DNA integrity and cell proliferation by regulating PGC-1α-mediated mitochondrial oxidative
1Molecular Biology and Lung Cancer Program, Lovelace Respiratory Research Institute, 2425 Ridgecrest DR. SE, Albuquerque, NM, USA.
Abstract:
Aerobic glycolysis or the Warburg effect contributes to cancer cell proliferation; however, how this glucose metabolism pathway is precisely regulated remains elusive. Here we show that receptor-interacting protein 1 (RIP1), a cell death and survival signaling factor, regulates mitochondrial oxidative phosphorylation and aerobic glycolysis. Loss of RIP1 in lung cancer cells suppressed peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) expression, impairing mitochondrial oxidative phosphorylation and accelerating glycolysis, resulting in spontaneous DNA damage and p53-mediated cell proliferation inhibition. Thus, although aerobic glycolysis within a certain range favors cancer cell proliferation, excessive glycolysis causes cytostasis. Our data suggest that maintenance of glycolysis by RIP1 is pivotal to cancer cell energy homeostasis and DNA integrity and may be exploited for use in anticancer therapy.
Insights
Receptor-interacting protein 1 (RIP1) regulates cancer cell metabolism. Loss of RIP1 impairs energy production, causing DNA damage and inhibiting proliferation, suggesting RIP1 as an anticancer target.
Area of Science:
- Cancer Biology
- Metabolic Regulation
- Molecular Signaling
Background:
- Aerobic glycolysis (Warburg effect) fuels cancer cell proliferation, but its precise regulation is unclear.
- Receptor-interacting protein 1 (RIP1) is a known factor in cell death and survival pathways.
- Understanding metabolic regulation is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the role of RIP1 in regulating glucose metabolism and mitochondrial function in cancer cells.
- To elucidate the downstream effects of RIP1 loss on cellular processes like DNA integrity and proliferation.
- To explore the therapeutic potential of targeting RIP1-mediated metabolic pathways.
Main Methods:
- Utilized lung cancer cell models with RIP1 manipulation (loss-of-function).
- Assessed mitochondrial oxidative phosphorylation (OXPHOS) and aerobic glycolysis rates.
- Analyzed peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) expression.
- Evaluated DNA damage and p53-mediated cell proliferation inhibition.
Main Results:
- Loss of RIP1 suppressed PGC-1α expression, leading to impaired mitochondrial OXPHOS.
- RIP1 deficiency accelerated aerobic glycolysis and induced spontaneous DNA damage.
- Excessive glycolysis, triggered by RIP1 loss, resulted in p53-dependent cytostasis and proliferation inhibition.
- RIP1 maintains glycolysis for cancer cell energy homeostasis and DNA integrity.
Conclusions:
- RIP1 is a critical regulator of both mitochondrial respiration and aerobic glycolysis in cancer.
- RIP1's role in maintaining metabolic balance is essential for cancer cell survival and proliferation.
- Targeting RIP1's metabolic regulatory function presents a potential strategy for anticancer therapy.
Related Concept Videos
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
piRNA - Piwi-interacting RNAs
Regulation of the Unfolded Protein Response

